Hertzel Gerstein talks with The Lancet Diabetes & Endocrinology about how dulaglutide might reduce the incidence of moderate or severe erectile dysfunction in men with type 2 diabetes.
Read the full article:
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00115-7/fulltext